REGADO BIOSCIENCES
Regado Biosciences is a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. It provides REG1 that is used in patients suffering from acute coronary syndrome who undergo coronary revascularization procedures, which include coronary artery bypass grafting and percutaneous coronary intervention. It was founded in 2001 and headquartered in Durham, North Carolina.
REGADO BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2001-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.regadobiosciences.com
Total Employee:
11+
Status:
Active
Contact:
19083250239
Total Funding:
154 M USD
Technology used in webpage:
SSL By Default IPv6 Cloudflare Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS Cloudflare SSL
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Baxter Ventures
Baxter Ventures investment in Series E - Regado Biosciences
The Aurora Funds
The Aurora Funds investment in Series E - Regado Biosciences
RMI Partners
RMI Partners investment in Series E - Regado Biosciences
Caxton Advantage Life Sciences Fund
Caxton Advantage Life Sciences Fund investment in Series E - Regado Biosciences
Andera Partners
Andera Partners investment in Series E - Regado Biosciences
RUSNANO
RUSNANO investment in Series E - Regado Biosciences
Quaker Partners
Quaker Partners investment in Series E - Regado Biosciences
Domain Associates
Domain Associates investment in Series E - Regado Biosciences
Quaker BioVentures
Quaker BioVentures investment in Series D - Regado Biosciences
The Aurora Funds
The Aurora Funds investment in Series D - Regado Biosciences
Official Site Inspections
http://www.regadobiosciences.com
- Host name: 172.67.133.147
- IP address: 172.67.133.147
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago